Trending News
News
News
Protecting Yourself from Mosquitoes Just Got Easier
New GoClip™ from RESCUE!® offers six days of protection from mosquitoes as well as biting flies and ticks.
News
Origins of Life Delivered from Space
Researchers have for the first time shown that ribose, a sugar that is one of the building blocks of genetic material in living organisms, may have formed in cometary ices.
News
Researchers develop blood test that detects early Alzheimer's disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body's immune response system to detect an early stage of Alzheimer's disease—referred to as the mild cognitive impairment (MCI) stage—with unparalleled accuracy.
News
Study highlights multiple factors of ADHD medication use
Youth who take Ritalin, Adderall or other stimulant medications for ADHD over an extended period of time early in life are no more at risk for substance abuse in later adolescence than teens without ADHD, according to a University of Michigan (U-M) study.
News
Metabolite of multiple sclerosis drug could be safe, effective therapy for Parkinson's disease
The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say.
News
Stress exposure during pregnancy observed in mothers of children with autism
More research needed to understand gene-stress interaction.
News
Philipp von Loeper to be New Chairman of the Supervisory Board of Eppendorf AG
Klaus Fink resigns as Chairman after five years
News
Cellectricon and Neurexpert Collaborate To Offer Enhanced offering In CNS Drug Discovery
Company has announced its collaboration with Neurexpert Ltd to provide of advanced cell-based discovery services.
News
Presentation of the 2016 Eppendorf Award for Young European Investigator to Adrian Liston
This year’s research prize awarded by Eppendorf goes to Belgium.
News
Aprea Ab Announces Efficacy And Safety Data In High-Grade Serous Ovarian Cancer
The company claims that APR-246 can be successfully combined with standard chemotherapy for ovarian cancer with minimal additional toxicity.
Advertisement